Persistent recruitment delays, high dropout rates, and missed timelines continue to slow global clinical trials, while data show that sub-Saharan Africa offers a largely untapped opportunity with ...

In today’s ultra-competitive global marketplace, life sciences companies are continually seeking ways to improve their research effectiveness and efficiency. Increasingly, real-world data (RWD) is ...

The clinical trials arena is becoming increasingly data-driven, with demand growing for sponsors to have real-time data access and ongoing updates throughout a study rather than just a final report.

Serious Games for Serious Pain: Development and Initial Testing of a Cognitive Behavioral Therapy Game for Patients With Advanced Cancer Pain Longitudinal patient tolerability data collected as part ...

Digital patient profiles and real-world data enhance oncology trial design, patient recruitment, and reduce trial failure risks. Phesi's platform aligns trial designs with real-world data, minimizing ...

Beam Therapeutics has presented the first clinical data on its base editing technology. All four sickle cell disease patients in the efficacy cohort had fetal hemoglobin levels above Beam’s target—and ...

A UCR study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country’s racial and ethnic ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

You're deep in clinical research operations, and decentralized clinical trials software has become the go-to for handling ...